Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update

Cumberland Pharmaceuticals (CPIX) Tops Q3 EPS by 9c

November 10, 2020 4:20 PM EST

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.02, $0.09 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.3 million versus the consensus estimate of $8.61 million.

At September 30, 2020, Cumberland had $96.0 million in total assets including $26.6 million in cash and cash equivalents. Total liabilities were... More